Frequency of deranged blood lipids in male patients with androgenetic alopecia

Dr. Bilquees, Nighat Akbar, Kiran Fatima


Objective To determine the frequency of deranged serum lipids in male patients with androgenetic alopecia.


Methods Cross-sectional study was conducted in the outpatients department of Dermatology, Fauji Foundation Hospital Rawalpindi over a period of six months i.e. January 2015 to June 2015. Male patients between 25-65 years with androgenetic alopecia were enrolled in the study. Blood samples for fasting serum lipids were taken during the same visit. All data were entered and analyzed.


Results Total 150 patients were included in the study according to the inclusion criteria. Mean age in high and low triglycerides patients was 46.87+10.58 years and 42.32+11.29 years, respectively. Similarly, mean age (years) in normal and low HDL was 42.17+10.87 years and 48.13+10.21 years, respectively. There were 131 (87.3%) patients who presented with high triglycerides levels whereas 19 (12.7%) patients had normal triglycerides. Similarly, there were 46 (30.7) patients who presented with normal HDL levels where as 104 (69.3) patients had low HDL levels.


Conclusion The study concluded that serum lipids were deranged in male patients of androgenetic alopecia.



Androgenetic alopecia, high-density lipoproteins, low-density lipoproteins, triglycerides

Full Text:



Fatemi F, Rahmaniyan N, Vatankhah M, Hashemi F. Prevalence of androgenetic alopecia in women of 20-70 years in Isfahan during 2008-2009. J Pak Assoc Dermatol. 2010;20:75-8.

Sharquie KE, Noaimi AA, Salman HA, Hindy NA. Female pattern alopecia and lipoproteins. IPMJ. 2009;8:120-3.

Farajzadeh S, Esfandiarpour I, Abbasi MMH, Moghaddam SD, Hossininasab F. Evaluation of Lipid profile in women with female pattern alopecia. Iran J Dermatol. 2010;13:78-81.

Kapadia N, Ahmed TJ, Borhany T. Male androgenetic alopecia treated with finasteride. J Pak Assoc Dermatol. 2008;18:232-4.

Stough D, Stenn K, Haber R***, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. 2005;80:1316-22

Arias-Santiago S, Arrabal-Polo MA, Buendía-Eisman A***, et al. Androgenetic alopecia as an early marker of benign prostatic hyperplasia. J Am Acad Dermatol. 2012;66:401-8.

Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17:220-2.

Arias-Santiago S, Gutierrez-Salmeron MT, Castellote-Caballero L, Buendia-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women. J Am Acad Dermatol. 2010;63:420-9.

Arias-Santiago S, Gutierrez-Salmeron MT, Buendia-Eisman A, Giron-Prieto MS, Naranjo-Sintes R. A comparative study of dyslipidemia in men and women with androgenetic alopecia. Acta Derm Venereol. 2010;90:485-7.

Sadighha A, Zahed GM. Evaluation of lipid levels in androgenetic alopecia in comparison with control group. J Eur Acad Dermatol Venereol. 2009;23:80-1.

Nabai L, Kavand S, Robati RM, Sarraffirad N, Shagholi L, Meshkat-Razavi G. Androgenetic alopecia and insulin resistance: are they really related? Clin Exp Dermatol. 2009;34:694-7.


  • There are currently no refbacks.

ISSN: 1560-9014